Breaking News
Subscribe Now 0
Q3 Earnings Alert! Plan early for this week’s stock reports with all key data in 1 place See list

Search Results for "cells":

Results: 7,235

Quotes

4880 Cellsource Co Ltd Stock - Tokyo equities FROG Frog Cellsat Ltd Stock - NSE equities 7776 CellSeed Inc Stock - Tokyo equities SCSP Stem Cells Spin SA Stock - Warsaw equities
Show all (4)

News

Genprex Collaborators to Present Positive Preclinical Data on the Use of Reqorsa ® Gene Therapy at the 2024 EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
By Investing.com

Reqorsa ® Gene Therapy Overcomes Acquired Resistance to Lumakras ® in Lung CancerREQORSA Demonstrated Potent Tumor Suppressive Activity in MesotheliomaREQORSA Induces Apoptosis in...

Defensive sectors prop up Europe's STOXX 600 as China jitters persist
By Reuters

(Reuters) - European stocks eked out gains on Wednesday, aided by defensive sectors, as uncertainty around China's stimulus plans kept the mood subdued ahead of key U.S. inflation data later this...

MiNK Therapeutics stock gets boost from new RNA collaboration with Autonomous
By Investing.com

On Wednesday, H.C. Wainwright reaffirmed its Buy rating and $9.00 price target for MiNK Therapeutics (NASDAQ:INKT) following the announcement of a research collaboration between MiNK and Autonomous...

Show all (6,248)

Analysis

BrainStorm Cell Therapeutics' Stem Cells Target ALS
By Edison

Brainstorm Cell Therapuetics Inc's (NASDAQ:BCLI) NurOwn enables extracted mesenchymal stem cells (MSCs) to express neurotrophic factors that can support cells affected by neurodegenerative diseases....

Neuralstem: Evidence Increasingly Suggests Its Stem Cells Are Effective
By Myriad Equity

Thoughts on the Stock Price I have been recommending Neuralstem (CUR) since my initiation report of November 5, 2012 at a price of $0.92. The stock has appreciated significantly over the past year and...

Celyad: First “Clinical Validity” For NKR CAR T-Cells
By Edison

Celyad SA (NASDAQ:CYAD) has reported a complete morphological leukaemia-free status (MFLS) response in acute myeloid leukaemia (AML) in the NKR CAR T-cell THINK study. Given that spontaneous remission...

Show all (983)
Results: 4

Refine Results

Instrument Type

Region

 

Country

Exchange

Sector

 

Industry

 
Results: 6,248

Refine Results

Date

Date
 

Category

Provider

 

News

{{title}}
By {{provider}}

{{content}}

Please try another search

Results: 983

Refine Results

Date

Date
 

Category

Author

Analysis

{{title}}
By {{provider}}

{{content}}

Results: 0

Refine Results

Country

Importance

Economic Events

Results: 0

Tools & Sections

Results: 0

Authors

Continue with Apple
Continue with Google
or
Sign up with Email